Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
49.7M
-
Number of holders
-
256
-
Total 13F shares, excl. options
-
47.6M
-
Shares change
-
+1.35M
-
Total reported value, excl. options
-
$2.87B
-
Value change
-
+$86.3M
-
Put/Call ratio
-
0.79
-
Number of buys
-
124
-
Number of sells
-
-117
-
Price
-
$60.34
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2014
285 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q1 2014.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 256 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.6M shares
of 49.7M outstanding shares and own 95.79% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.57M shares), WELLINGTON MANAGEMENT CO LLP (2.57M shares), ARIEL INVESTMENTS, LLC (2.01M shares), Invesco Ltd. (1.75M shares), PRIMECAP MANAGEMENT CO/CA/ (1.7M shares), Fairpointe Capital LLC (1.56M shares), FMR LLC (1.51M shares), BlackRock Institutional Trust Company, N.A. (1.45M shares), BlackRock Fund Advisors (1.31M shares), and BlackRock Advisors LLC (1.24M shares).
This table shows the top 256 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.